This NDC is on FDA's drug shortage list (posted Jul 26, 2023)
Product Information
CONCERTA ER 18 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $12.3253 per EA under NDC 50458058501. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 1, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Methylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
18 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458058501
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021121FDA Approved
8/1/2000
TE Code
AB
On Market Since
8/1/2000
Pharmacological Classes
Price Statistics
The NADAC for CONCERTA ER 18 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 80.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.3253 per EA |
|---|---|
| All-time high | $12.3598 (Mar 12, 2025) |
| All-time low | $6.8277 (Nov 28, 2013) |
| 52-week high | $12.3501 |
| 52-week low | $12.3253 |
| Median price | $11.2704 |
| Average price | $10.6762 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CONCERTA ER 18 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CONCERTA ER 18 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $12.3253 per EA (NDC 50458058501), effective Sep 30, 2026.
How has the price of CONCERTA ER 18 MG TABLET changed over time?
Over the history we have for it, the NADAC for CONCERTA ER 18 MG TABLET has risen 80.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CONCERTA ER 18 MG TABLET?
Since Nov 28, 2013, the NADAC for CONCERTA ER 18 MG TABLET has ranged from a low of $6.8277 (Nov 28, 2013) to a high of $12.3598 (Mar 12, 2025), with a median of $11.2704 per EA.
Are there cheaper alternatives to CONCERTA ER 18 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER 18 MG TAB, is $0.5761 per EA — about 95% below CONCERTA ER 18 MG TABLET.
Who manufactures CONCERTA ER 18 MG TABLET?
CONCERTA ER 18 MG TABLET (NDC 50458058501) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.
Is CONCERTA ER 18 MG TABLET in shortage?
Yes — NDC 50458058501 is currently listed in FDA's drug shortage database (posted Jul 26, 2023).